Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Z Hautkr ; 58(6): 410-6, 1983 Mar 15.
Artigo em Alemão | MEDLINE | ID: mdl-6857758

RESUMO

In 20 volunteers, we were able to demonstrate experimentally that side-effects of anthralin application on healthy skin development of erythema and pigmentation, can be significantly reduced in a short contact therapy, in comparison to a longterm treatment. The oxydation products 1.8-dihydroxy-9.10-anthraquinone and 10.10'-dimer which are considered the main impurities of anthralin do not cause any irritation on healthy skin.


Assuntos
Antracenos , Antralina , Antraquinonas/efeitos adversos , Pele/efeitos dos fármacos , Antralina/efeitos adversos , Antralina/análogos & derivados , Relação Dose-Resposta a Droga , Eritema/induzido quimicamente , Humanos , Oxirredução
5.
Z Hautkr ; 50(3): 105-12, 1975 Feb 01.
Artigo em Alemão | MEDLINE | ID: mdl-179231

RESUMO

The results of treatment with LUPIDON achieved by 215 dermatologists with reference to a total number of 1059 cases are reported taking into account the controlled evaluation of questionnaires. Due to the considerable number of patients and physicians involved in this clinical investigation the presuppositions for objectiveness in respect of statistical evaluation were especially favourable. The results of treatment with LUPIDON--LUPIDON H and LUPIDON G proved to be of equal effectiveness--can be denoted as very positive because of the good or very good effects that could be observed in more than 80% of all the cases concerned. Such a therapeutically favourable result refers primarily to Herpes labialis, Herpes genitalis and Herpes eruptions infesting trunk and head; other types of herpes disease, for example Herpes glutealis or stomatitis aphthosa were only improved to about 60%. The compatability of LUPIDON was striking. The rate of side-effects was at 3%. Moreover, other series of data are given with the intention to inform about criteria such as: Frequency of localisations with regard to Herpes simplex diseases; distribution according to sex of patients being suffering from Herpes labialis and Herpes genitalis; distribution according to age; duration of Herpes simplex before starting a treatment with LUPIDON; accompanying skin diseases.


Assuntos
Antígenos Virais/uso terapêutico , Herpes Simples/terapia , Simplexvirus/imunologia , Adolescente , Adulto , Fatores Etários , Idoso , Criança , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Recidiva
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...